Valeo Pharma logo — Providing healthcare professionals and patients with innovat...

Valeo Pharma

Providing healthcare professionals and patients with innovative therapeutic solutions to improve quality of life.

Founded 2003 Canada Canada 88 employees Post-IPO Debt Total: $106.60M Biotechnology, Health Care +1

General Information

Company Name Valeo Pharma
Founded Year 2003
Location Canada Canada
Founders / Decision Makers
Team member
Employees 88
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Post-IPO Debt
Social

BounceWatch is an independent company data service, not affiliated with Valeo Pharma. To contact Valeo Pharma, visit valeopharma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Valeo Pharma compare?

A PDF of Valeo Pharma and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Valeo Pharma soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Valeo Pharma

Valeo Pharma is a Canadian pharmaceutical company established in 2003, specializing in the commercialization of innovative prescription products within Respiratory/Allergy, Ophthalmology, and Hospital Specialty Products. With headquarters in Kirkland, Quebec, Valeo Pharma boasts comprehensive capabilities and infrastructure for product registration and management throughout the commercialization process. The company's commitment to improving healthcare is encapsulated in its slogan: "Providing healthcare professionals and patients with innovative therapeutic solutions to improve quality of life." Their fast growth and dedication to enhancing the quality of life through innovative therapeutic solutions make Valeo Pharma an intriguing prospect for potential investors. As an up-and-coming player in the Canadian pharmaceutical landscape, the company presents an attractive investment opportunity. With a sharp focus on addressing unmet medical needs, Valeo Pharma's strategic positioning within the healthcare industry positions it well for future success. For more insights, please visit www.valeopharma.com.

Business keywords: Pharmaceuticals, Innovative Therapeutic Solutions, Healthcare Professionals, Patients, Quality of Life, Canadian Company, Prescription Products, Respiratory/Allergy, Ophthalmology, Hospital Specialty Products, Commercialization, Product Portfolio Management, Healthcare Innovation, Medical Infrastructure, Canadian Pharmaceutical Industry

Funding Rounds & Investors (10)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Debt $5.00M 1
Accord Financial, Inc. (U.S.)
27 Sep 2023
Post IPO Equity $3.92M -
31 Aug 2023
Post IPO Debt $580.00K -
31 Aug 2023
Post IPO Debt $40.00M 1
Sagard Healthcare Royalty Partners
02 Aug 2022
Post IPO Debt $25.00M 1
Investissement Québec
09 Dec 2021
Post IPO Equity $11.50M -
29 Jun 2021
Post IPO Debt $6.60M -
27 Apr 2021
Post IPO Equity $6.90M -
10 Sep 2020
Post IPO Equity $4.00M -
06 Nov 2019
Post IPO Equity $3.10M -
25 Jul 2019

Valeo Pharma Alternatives & Competitors

View All Alternatives
Valeo Pharma vs

Searchlight Pharma is a Montreal-based company with global reach that executes best-in-class search,...

Private Equity
57 employees
Health Care, Pharmaceutical
Valeo Pharma vs

Paladin Labs Inc., headquartered in Montreal, Canada, is a specialty pharmaceutical company focused...

Post-IPO Equity
132 employees
Biotechnology, Health Care
Valeo Pharma vs

Leading Innovation and Quality in Dialysis Solutions for Greece and Beyond #Revolutionizing Renal Ca...

19 employees
Health Care, Manufacturing

FAQ About Valeo Pharma

Providing healthcare professionals and patients with innovative therapeutic solutions to improve quality of life.
Valeo Pharma was founded in 2003.
Valeo Pharma is headquartered in Canada.
Valeo Pharma operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on Pharmaceuticals, Innovative Therapeutic Solutions, Healthcare Professionals and Patients.
Valeo Pharma has approximately 88 employees.
Valeo Pharma has completed 10 funding rounds, raising a total of $106.60M. The latest funding stage is Post-IPO Debt.
Top alternatives and competitors to Valeo Pharma include Searchlight Pharma Inc., Paladin Labs, Verma Drugs S.A., VEM PHARMACEUTICALS, Juvenor Pharma. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Valeo Pharma and Searchlight Pharma Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Valeo Pharma, https://bouncewatch.com/company/valeo-pharma, updated 31 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes